Back to Results
First PageMeta Content
Ribbon symbolism / Oncotype DX / MammaPrint / Tamoxifen / Adjuvant therapy / National Comprehensive Cancer Network / HER2/neu / Breast cancer classification / Breast cancer treatment / Medicine / Oncology / Breast cancer


original articles Annals of Oncology
Add to Reading List

Open Document

File Size: 398,32 KB

Share Result on Facebook

City

Bruxelles / Cologne / Nice / Vienna / Linz / London / Villejuif / Brussels / /

Company

Cancer Translational Research Laboratory / Sividon Diagnostics GmbH / Oxford University Press / Breast Cancer Translational Research Laboratory / 9Translational Cancer Therapeutics Laboratory / 13Bayer Technology Services GmbH / 14Sividon Diagnostics / Creative Commons / /

Country

Belgium / France / Austria / United States / /

/

Event

FDA Phase / /

Facility

Paracelsus University of Salzburg / Virchows Arch / University of Dundee / Comprehensive Cancer Center / University of Mainz / Medical University / Cancer Institute / Hospital of St Poelten / London Research Institute / University of Texas / General Hospital of Linz / Hospital Guessing / Catholic University of Leuven / Medical University of Vienna / /

/

IndustryTerm

multigene algorithms / Cancer Therapeutics / therapy of early breast cancer / breast cancer therapy / therapy for breast cancer / therapy for early breast cancer / /

MedicalCondition

Her2- breast cancer / endocrine-responsive early breast cancer / metastasis / estrogen receptor-positive breast cancer / early breast cancer / human cancers / tamoxifen-treated / node-negative breast cancer / B breast cancer / positive/HER2-negative breast cancer / distant metastasis / hormone receptor-positive disease / biological breast cancer / HER2-negative postmenopausal breast cancer / B tumors / HER2-negative disease / postmenopausal breast cancer / node-negative breast carcinoma / luminal breast cancer / lymph-node-negative primary breast cancer / breast cancer / tamoxifen-treated estrogen receptor-positive breast cancer / adjuvant breast cancer / breast and colorectal cancer / tumor / G3 tumors / larger tumors / HER2-negative tumors / lymph-node-negative / oestrogen-receptor-positive breast cancer / Cancer / tumors / HER2-negative breast cancer / negative tumors / expression introduction Breast cancer / node-negative breast cancer / HER2negative breast cancer / HER2-negative early breast cancer P. Dubsky1 / ERpositive breast cancer / /

MedicalTreatment

chemo / adjuvant chemotherapy / endocrine therapy / breast cancer therapy / chemotherapy / Surgery / molecular therapies / hormonal therapy / adjuvant therapy / /

Organization

Comprehensive Cancer Center Vienna / General Hospital of Linz / Hospital of St Poelten / 10UCL Cancer Institute / Medical University Vienna / Dundee Cancer Centre / University of Texas / Houston / University of Vienna / London Research Institute / University of Mainz / Department of Experimental Oncology / University of Salzburg / Oxford University / UCL Hospitals Macmillan Cancer Centre / European Society for Medical Oncology / Department of Medical Oncology / Department of Surgery / University of Dundee / Catholic University of Leuven / Department of Obstetrics and Gynecology / /

Person

Gustave Roussy / P. Dubsky / Jules Bordet / F. André / Ann Surg Oncol / Ann Oncol / /

/

Position

Author / Fisher / /

Product

Ki67 / anastrozole / EPclin / ABCSG-8 / ABCSG6 / /

ProvinceOrState

Texas / /

Technology

gene expression / chemotherapy / treating cancer / multigene algorithms / pharmacodynamics / /

URL

http /

SocialTag